University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Pharmacist supplementary prescribing: A step toward more independence?

Dawoud, D, Griffiths, P, Maben, Jill, Goodyer, L and Greene, R (2010) Pharmacist supplementary prescribing: A step toward more independence? Research in Social and Administrative Pharmacy, 7 (3). pp. 246-256.

Full text not available from this repository.

Abstract

Background

Supplementary prescribing (SP) is a drug therapy management model implemented in the United Kingdom since 2003. It is a voluntary partnership between an independent prescriber; a supplementary prescriber, for example, nurse or pharmacist; and the patient, to implement an agreed patient-specific clinical management plan (CMP).

Objective

To investigate pharmacist prescribers' views and experiences of the early stages of SP implementation.

Methods

A qualitative, longitudinal study design was used. A purposive, maximum variability sample of 16 pharmacist supplementary prescribers, trained in Southern England, participated. Eleven were hospital pharmacists, owing to the overrepresentation of hospital pharmacists in the first cohort. Two semistructured interviews were conducted with each participant, at 3 and 6 months after their registration as prescribers. The Framework approach was used for data collection, management, and analysis.

Results

Three typologies of pharmacists' experiences were identified: “a blind alley”, “a stepping stone” and “a good fit”. Despite some delays in its implementation, SP was seen as a step forward. Some participants also believed that it improved patient care and pharmacists' integration in the health care team and increased their job satisfaction. However, there was a concern that SP, as first implemented, was bureaucratic and limited pharmacists' freedom in their decision making. Hence, pharmacists were more supportive of the then imminent introduction of a pharmacist independent prescribing (IP) role.

Conclusions

Despite challenges, the SP role represented a step forward for pharmacists in the United Kingdom. It is possible that pharmacist SP can coexist with IP in the areas suitable for CMP use. Elsewhere, SP is likely to become more of a “stepping stone” to an IP role than the preferred model for pharmacist prescribing. Future research needs to objectively assess the outcomes of pharmacist SP, preferably in comparison with IP, to inform decision making among pharmacists regarding the adoption of such an innovative role.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Health Sciences
Authors :
NameEmailORCID
Dawoud, D
Griffiths, P
Maben, Jillj.maben@surrey.ac.uk
Goodyer, L
Greene, R
Date : 23 July 2010
Identification Number : 10.1016/j.sapharm.2010.05.002
Copyright Disclaimer : Copyright © 2011 Elsevier Inc. All rights reserved.
Uncontrolled Keywords : United KingdomPharmacistSupplementary prescribingDrug therapy managementQualitativeFramework analysis
Depositing User : Melanie Hughes
Date Deposited : 15 Dec 2017 09:43
Last Modified : 15 Dec 2017 09:43
URI: http://epubs.surrey.ac.uk/id/eprint/845290

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800